Advanced endoscopic technique successfully treats early-stage colorectal cancer
In the months before his wedding, Queens resident Roberto Pineda Sanchez noticed persistent rectal bleeding, a dangerous symptom…
AI-assisted decision support system improves stroke care and long-term outcomes
A clinical decision support tool that uses artificial intelligence (AI) to analyze scans after a stroke alongside treatment…
Canadian wildfire pollution associated with increased stroke severity
Short-term surges in air pollution in New Jersey from the 2023 Canadian wildfires were associated with a higher…
AI-driven model enhances treatment decisions for cancer patients after heart attack
Cancer patients who suffer a heart attack face a dangerous mix of risks, which makes their clinical treatment…
Antidepressant use does not worsen early outcomes after traumatic brain injury
Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased…
Daily tracking menstrual cycles show affects on athletes
New research shows that real-time daily tracking, rather than memory-based surveys, reveals the true timing, frequency, and performance…
New trial to test extended tranexamic acid use for faster ACL surgery recovery
A breakthrough could be coming in the way young people recover from surgery to reconstruct the anterior cruciate…
Language in AMA Discharge Notes: Watch it!
More than 500,000 patients leave US hospitals each year against medical advice (AMA), in the process facing risks…
Should you be taking daily aspirin for your heart?
It was once thought that taking daily aspirin was an effective way to prevent cardiovascular disease. But a…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…